Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

SchnellGen Inc
Profile last edited on: 7/16/2023      CAGE: 59DK8      UEI: GNZNX2NJQAV7

Business Identifier: Novel therapeutics for the treatment of acute organ failure and wound healing
Year Founded
2008
First Award
2010
Latest Award
2012
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

794 Olde Central Way
Mount Pleasant, SC 29464
   (843) 367-3851
   N/A
   N/A
Location: Single
Congr. District: 01
County: Charleston

Public Profile

SchnellGen is a start-up company of the Cancer Drug Discovery Center. Its mission is to develop novel therapeutics for the treatment of acute organ failure and wound healing.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$269,288
Phase II Dollars
$1,608,122
Total Awarded
$1,877,410

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2012 2 NIH $1,877,410
Project Title: High Throughput Mitochondrial Nephrotoxicant Assay

Key People / Management

  Rick G Schnellmann -- President

  Craig Beeson

Company News

There are no news available.